PrEP HIV Prevention Pills to Be Free for Insured Americans
WEDNESDAY, July 21, 2021 -- Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada and Descovy, all clinic visits,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2021 Category: Pharmaceuticals Source Type: news
PrEP HIV Prevention Pills to Be Free for Insured Americans
Nearly all health insurers must cover the entire cost of HIV prevention treatments. The two approved pre-exposure prophylaxis (PrEP) drugs are Truvada and Descovy. (Source: WebMD Health)
Source: WebMD Health - July 21, 2021 Category: Consumer Health News Source Type: news
PrEP HIV Prevention Pills to Be Free for Insured Americans
WEDNESDAY, July 21, 2021 -- Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says.
That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada and Descovy, all clinic visits... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 21, 2021 Category: General Medicine Source Type: news
Lupin gets USFDA nod to market generic HIV drug
The company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 7, 2021 Category: Pharmaceuticals Source Type: news
Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)
Title: Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)Category: MedicationsCreated: 5/27/2021 12:00:00 AMLast Editorial Review: 5/27/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 27, 2021 Category: Drugs & Pharmacology Source Type: news
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)
Title: Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)Category: MedicationsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - April 30, 2021 Category: Infectious Diseases Source Type: news
Strides Pharma Science arm gets USFDA nod for HIV treatment drug
Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used to treat HIV. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2021 Category: Pharmaceuticals Source Type: news
Shot to Prevent H.I.V. Works Better Than Daily Pill in Women
Researchers ended a clinical trial of the drug early because the results were so convincing. The more effective drug would be given in six injections a year instead of as 365 daily pills. (Source: NYT Health)
Source: NYT Health - November 9, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Clinical Trials Acquired Immune Deficiency Syndrome Women and Girls Truvada (Drug) Drugs (Pharmaceuticals) Viiv Healthcare Ltd Gilead Sciences Inc Source Type: news
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate)
Title: Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate)Category: MedicationsCreated: 10/28/2020 12:00:00 AMLast Editorial Review: 10/28/2020 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - October 28, 2020 Category: Infectious Diseases Source Type: news
Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)
Title: Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)Category: MedicationsCreated: 10/6/2020 12:00:00 AMLast Editorial Review: 10/6/2020 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - October 6, 2020 Category: Infectious Diseases Source Type: news
Insurer, Insured Costs for HIV PrEP Rising in the United States
WEDNESDAY, Sept. 9, 2020 -- From 2014 to 2018, there were increases noted in third-party and out-of-pocket (OOP) payments per 30 tenofovir disoproxil fumarate with emtricitabine (TDF-FTC) tablets for HIV preexposure prophylaxis (PrEP), according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2020 Category: Pharmaceuticals Source Type: news
' Vacation PrEP': Short-Term HIV Prevention a Viable Option
THURSDAY, Aug. 27, 2020 -- The daily use of antiretroviral meds to help prevent HIV infection has been around for a few years now -- it ' s called pre-exposure prophylaxis, or PrEP.
PrEP includes combo drugs such as Truvada (tenofovir/emtricitabine).... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 27, 2020 Category: General Medicine Source Type: news
GSK Says Long-Acting HIV Prevention Drug 65% More Effective Than Truvada GSK Says Long-Acting HIV Prevention Drug 65% More Effective Than Truvada
Britain ' s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 65% more effective in preventing HIV infections than Gilead ' s Truvada daily oral pills.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 8, 2020 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
A Shot to Protect Against H.I.V.
A drug injected every two months is more effective at preventing H.I.V. infection than a daily pill, scientists report. (Source: NYT Health)
Source: NYT Health - July 7, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Acquired Immune Deficiency Syndrome Truvada (Drug) Drugs (Pharmaceuticals) Women and Girls Transgender and Transsexuals Clinical Trials Gilead Sciences Inc Viiv Healthcare Ltd Brazil your-feed-science Source Type: news
Brazilian AIDS Patient Shows No Sign of Virus After Experimental Drug Therapy
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday.
The case needs independent verification and it’s way too soon to speculate about a possible cure, scientists cautioned.
“These are exciting findings but they’re very preliminary,” said Dr. Monica Gandhi, an AIDS specialist at the University of California, San Francisco. “This has happened to one person, and one person only,” and it didn’t suc...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Marilynn Marchione / AP Tags: Uncategorized HIV/AIDS News Desk wire Source Type: news
